Cargando…

Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection

BACKGROUND: Impulsivity, affective instability, and neglect of oneself and other people's safety as symptoms of personality dysfunction are associated with risky behaviors regarding the transmission of infectious diseases either sexually or by intravenous drug abuse. OBJECTIVE: The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Skočibušić, Siniša, Zivlak-Radulović, Nera, Hasanović, Mevludin, Awad, Hassan, Karan-Križanac, Dragana, Mehić-Basara, Nermana, Rukavina, Tomislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507475/
https://www.ncbi.nlm.nih.gov/pubmed/36159261
http://dx.doi.org/10.3389/fpubh.2022.1009413
_version_ 1784796869819367424
author Skočibušić, Siniša
Zivlak-Radulović, Nera
Hasanović, Mevludin
Awad, Hassan
Karan-Križanac, Dragana
Mehić-Basara, Nermana
Rukavina, Tomislav
author_facet Skočibušić, Siniša
Zivlak-Radulović, Nera
Hasanović, Mevludin
Awad, Hassan
Karan-Križanac, Dragana
Mehić-Basara, Nermana
Rukavina, Tomislav
author_sort Skočibušić, Siniša
collection PubMed
description BACKGROUND: Impulsivity, affective instability, and neglect of oneself and other people's safety as symptoms of personality dysfunction are associated with risky behaviors regarding the transmission of infectious diseases either sexually or by intravenous drug abuse. OBJECTIVE: The aim of this study was to analyze the association between hepatitis C virus (HCV) infection and personality dysfunction in opiate addicts on opioid substitution treatment. METHODS: This was a cross-sectional, observational investigation of patients over 18 years of age who were actively participating in opioid substitution treatment at five centers in Bosnia and Herzegovina. The occurrence of HCV infection was the primary study outcome, and personality functioning, the main independent variable, was assessed using the Severity Indices of Personality Problems (SIPP−118) questionnaire. The association between scores of personality functioning domains items and HCV infection status was determined by binary logistic regression analysis. RESULTS: Patients on opioid substitution therapy with HCV infection more frequently had personality disorders (OR 2.168, 95% CI 1.161–4.05) and were treated longer than patients without HCV infection (OR 1.076, 95% CI 1.015–1.14). HCV infection was associated with lower self-respect (OR 0.946, 95% CI 0.906–0.988), decreased capacity to have enduring relationships with other people (OR 0.878, 95% CI 0.797–0.966), and lower capability to cooperate with others (OR 0.933, 95%CI 0.888–0.98). On the other hand, except for self-respect, other elements of the Identity Integration domain (enjoyment, purposefulness, stable self-image, and self-reflexive functioning), when more functional, increased the risk of HCV infection. CONCLUSIONS: Our study demonstrates that opiate addicts on opioid substitution treatment have a higher risk of HCV infection if their personality is dysfunctional, especially in the aspects of self-respect, enduring relationships, and cooperativity. The risk is even higher in addicts who have an established diagnosis of any kind of personality disorder.
format Online
Article
Text
id pubmed-9507475
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95074752022-09-24 Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection Skočibušić, Siniša Zivlak-Radulović, Nera Hasanović, Mevludin Awad, Hassan Karan-Križanac, Dragana Mehić-Basara, Nermana Rukavina, Tomislav Front Public Health Public Health BACKGROUND: Impulsivity, affective instability, and neglect of oneself and other people's safety as symptoms of personality dysfunction are associated with risky behaviors regarding the transmission of infectious diseases either sexually or by intravenous drug abuse. OBJECTIVE: The aim of this study was to analyze the association between hepatitis C virus (HCV) infection and personality dysfunction in opiate addicts on opioid substitution treatment. METHODS: This was a cross-sectional, observational investigation of patients over 18 years of age who were actively participating in opioid substitution treatment at five centers in Bosnia and Herzegovina. The occurrence of HCV infection was the primary study outcome, and personality functioning, the main independent variable, was assessed using the Severity Indices of Personality Problems (SIPP−118) questionnaire. The association between scores of personality functioning domains items and HCV infection status was determined by binary logistic regression analysis. RESULTS: Patients on opioid substitution therapy with HCV infection more frequently had personality disorders (OR 2.168, 95% CI 1.161–4.05) and were treated longer than patients without HCV infection (OR 1.076, 95% CI 1.015–1.14). HCV infection was associated with lower self-respect (OR 0.946, 95% CI 0.906–0.988), decreased capacity to have enduring relationships with other people (OR 0.878, 95% CI 0.797–0.966), and lower capability to cooperate with others (OR 0.933, 95%CI 0.888–0.98). On the other hand, except for self-respect, other elements of the Identity Integration domain (enjoyment, purposefulness, stable self-image, and self-reflexive functioning), when more functional, increased the risk of HCV infection. CONCLUSIONS: Our study demonstrates that opiate addicts on opioid substitution treatment have a higher risk of HCV infection if their personality is dysfunctional, especially in the aspects of self-respect, enduring relationships, and cooperativity. The risk is even higher in addicts who have an established diagnosis of any kind of personality disorder. Frontiers Media S.A. 2022-09-09 /pmc/articles/PMC9507475/ /pubmed/36159261 http://dx.doi.org/10.3389/fpubh.2022.1009413 Text en Copyright © 2022 Skočibušić, Zivlak-Radulović, Hasanović, Awad, Karan-Križanac, Mehić-Basara and Rukavina. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Skočibušić, Siniša
Zivlak-Radulović, Nera
Hasanović, Mevludin
Awad, Hassan
Karan-Križanac, Dragana
Mehić-Basara, Nermana
Rukavina, Tomislav
Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection
title Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection
title_full Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection
title_fullStr Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection
title_full_unstemmed Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection
title_short Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection
title_sort personality dysfunction in opiate addicts on opioid substitution treatment and the risk of hcv infection
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507475/
https://www.ncbi.nlm.nih.gov/pubmed/36159261
http://dx.doi.org/10.3389/fpubh.2022.1009413
work_keys_str_mv AT skocibusicsinisa personalitydysfunctioninopiateaddictsonopioidsubstitutiontreatmentandtheriskofhcvinfection
AT zivlakradulovicnera personalitydysfunctioninopiateaddictsonopioidsubstitutiontreatmentandtheriskofhcvinfection
AT hasanovicmevludin personalitydysfunctioninopiateaddictsonopioidsubstitutiontreatmentandtheriskofhcvinfection
AT awadhassan personalitydysfunctioninopiateaddictsonopioidsubstitutiontreatmentandtheriskofhcvinfection
AT karankrizanacdragana personalitydysfunctioninopiateaddictsonopioidsubstitutiontreatmentandtheriskofhcvinfection
AT mehicbasaranermana personalitydysfunctioninopiateaddictsonopioidsubstitutiontreatmentandtheriskofhcvinfection
AT rukavinatomislav personalitydysfunctioninopiateaddictsonopioidsubstitutiontreatmentandtheriskofhcvinfection